219 related articles for article (PubMed ID: 4417442)
21. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
22. Specificities in human cell-mediated cytotoxicity.
Takasugi M; Akira D; Takasugi J; Mickey MR
J Natl Cancer Inst; 1977 Jul; 59(1):69-75. PubMed ID: 69035
[TBL] [Abstract][Full Text] [Related]
23. Workshop in human tumor immunology.
Oettgen HF; Bean MA; Klein G
Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
[No Abstract] [Full Text] [Related]
24. Immunity in the tumor-bearing host and its modification by serum factors.
Baldwin RW; Embleton MJ; Price MR; Robins A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1452-60. PubMed ID: 4422494
[No Abstract] [Full Text] [Related]
25. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
26. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
Hellström I; Warner GA; Hellström KE; Sjögren HO
Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
[No Abstract] [Full Text] [Related]
27. Enhancement phenomenon.
Petrányi GG
Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
[No Abstract] [Full Text] [Related]
28. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
Cummings FJ; Heppner GH; Stolbach L; Calabresi P
Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
[No Abstract] [Full Text] [Related]
29. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
Todd RF; Stulting RD; Berke G
Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
[No Abstract] [Full Text] [Related]
30. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
Cummings KB; Peter JB; Kaufman JJ
J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
[No Abstract] [Full Text] [Related]
31. Antigenic cross-reactivity between benign and malignant neoplasms of the human breast.
Avis F; Mosonov I; Haughton G
J Natl Cancer Inst; 1974 Apr; 52(4):1041-9. PubMed ID: 4826577
[No Abstract] [Full Text] [Related]
32. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
Jose DG; Seshadri R
Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
[No Abstract] [Full Text] [Related]
33. Proceedings: What is the clinical relevance of in-vitro tumour immunity test?
Moore M
Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139106
[No Abstract] [Full Text] [Related]
34. Relationship between blocking and unblocking activity and tumor growth in vivo.
Sjögren HO; Bansal SC
Natl Cancer Inst Monogr; 1972 Dec; 35():231-5. PubMed ID: 4349148
[No Abstract] [Full Text] [Related]
35. Mediation of immune responses to tumor antigens in vitro by immune RNA.
Kern DH; Drogemuller CR; Pilch YH
Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte-mediated immune responses in neoplasia.
Pilch YH; Golub SH
Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
[No Abstract] [Full Text] [Related]
37. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.
Baldwin RW; Embleton MJ; Robins RA
Proc R Soc Med; 1973 May; 66(5):466-8. PubMed ID: 4351926
[No Abstract] [Full Text] [Related]
38. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
Baldwin RW; Embleton MJ; Robins RA
Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609
[No Abstract] [Full Text] [Related]
39. Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test.
Takasugi M; Terasaki PI
J Natl Cancer Inst; 1972 Nov; 49(5):1229-37. PubMed ID: 4675381
[No Abstract] [Full Text] [Related]
40. Serum inhibitors of cellular immunity in human neuroblastoma. IgG subclass of blocking activity.
Jose DG; Skvaril F
Int J Cancer; 1974 Feb; 13(2):173-8. PubMed ID: 4856316
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
